Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bionano Genomics Inc (BNGO)

Bionano Genomics Inc (BNGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,552,019
  • Shares Outstanding, K 279,140
  • Annual Sales, $ 8,500 K
  • Annual Income, $ -41,110 K
  • 60-Month Beta 1.90
  • Price/Sales 173.66
  • Price/Cash Flow N/A
  • Price/Book 4.72
Trade BNGO with:

Options Overview

Details
  • Implied Volatility 86.01%
  • Historical Volatility 49.42%
  • IV Percentile 12%
  • IV Rank 8.51%
  • IV High 246.08% on 01/27/21
  • IV Low 71.12% on 08/27/21
  • Put/Call Vol Ratio 0.31
  • Today's Volume 15,950
  • Volume Avg (30-Day) 9,001
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 211,638
  • Open Int (30-Day) 219,352

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.12 +8.59%
on 09/15/21
6.08 -8.55%
on 09/02/21
+0.22 (+4.12%)
since 08/17/21
3-Month
5.12 +8.59%
on 09/15/21
8.20 -32.20%
on 06/28/21
-2.30 (-29.26%)
since 06/17/21
52-Week
0.47 +1,073.24%
on 11/06/20
15.69 -64.56%
on 02/16/21
+4.93 (+782.54%)
since 09/17/20

Most Recent Stories

More News
Study Finds the Combination of Optical Genome Mapping and Short-Read Sequencing Provides a Comprehensive Genome Analysis for Lung Cancer Samples and Enables the Discovery of New Biomarkers

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study finding the combination of optical genome mapping (OGM) and short-read next-generation sequencing (NGS) provides a comprehensive genome analysis...

BNGO : 5.56 (+5.10%)
NuProbe Global Adopts Bionano's Saphyr(R) System to Develop Products in Reproductive Health and Oncology Applications

Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano's Saphyr system for optical...

BNGO : 5.56 (+5.10%)
Bionano Genomics Announces ESHG Lineup Featuring 11 Customer Presentations of OGM Data Spanning Three Major Clinical Research Areas of Application from 10 Institutions and Six Countries

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference lineup featuring 11 customer presentations of optical genome mapping (OGM) data spanning three...

BNGO : 5.56 (+5.10%)
Bionano Genomics, Inc. (BNGO) Reports Q2 Loss, Tops Revenue Estimates

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -20.00% and 16.85%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

BNGO : 5.56 (+5.10%)
Bionano Genomics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Progress

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the second quarter ended June 30, 2021 and highlighted recent corporate updates.

BNGO : 5.56 (+5.10%)
Bionano (BNGO) to Report Q2 Earnings: What's in the Cards?

Bionano Genomics (BNGO) is likely to provide updates on earnings and revenues when it reports second-quarter 2021 results.

DVAX : 14.89 (+3.12%)
ADVM : 2.31 (+3.59%)
CRVS : 5.32 (+135.40%)
BNGO : 5.56 (+5.10%)
Bionano Genomics to Report Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 4, 2021

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 4, 2021 at 4:30 p.m. Eastern Time to report financial results for the second...

BNGO : 5.56 (+5.10%)
Bionano Genomics Announces a Record Number of Optical Genome Mapping Presentations Scheduled to Appear at the Annual Cancer Genomics Consortium Meeting from August 1st - 4th, 2021

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a record number of optical genome mapping (OGM) presentations scheduled to appear at the annual Cancer Genomics Consortium (CGC) meeting being held...

BNGO : 5.56 (+5.10%)
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $5.87, marking a -1.68% move from the previous day.

BNGO : 5.56 (+5.10%)
Bionano's Optical Genome Mapping for Acute Lymphoblastic Leukemia Subjects at the University Hospitals Leuven, Belgium, Has Faster Turnaround Time, Higher Success Rates and Lower Cost per Sample Compared to Traditional Methods

Bionano Genomics, Inc. (Nasdaq: BNGO) announces a summary of the results obtained by the University Hospitals Leuven, Belgium with optical genome mapping (OGM) with Bionano's Saphyr system. An assay was...

BNGO : 5.56 (+5.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San...

See More

Key Turning Points

3rd Resistance Point 5.90
2nd Resistance Point 5.73
1st Resistance Point 5.65
Last Price 5.56
1st Support Level 5.40
2nd Support Level 5.23
3rd Support Level 5.15

See More

52-Week High 15.69
Fibonacci 61.8% 9.88
Fibonacci 50% 8.08
Fibonacci 38.2% 6.29
Last Price 5.56
52-Week Low 0.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar